SAM
AVNS

Symphony Asset Management’s Avanos Medical AVNS Stock Holding History

Symphony Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-9,771
Closed -$480K – 416
2015
Q1 		$480K Buy
+9,771
New +$453K 0.06% 337

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
RP
RR Partners New York $929M AUM 110.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Symphony Asset Management's AVNS Position: Q2 2015 in Review

Symphony Asset Management sold out of Avanos Medical (AVNS) in Q2 2015, closing a stake of 9,771 shares — an estimated $480K sold.

Symphony Asset Management first reported a position in AVNS in Q1 2015 and held it in 1 quarter. The position peaked at $480K in Q1 2015. 419 funds tracked by Wall St. Rank hold AVNS as of Q2 2015.

  • Symphony Asset Management reported no remaining Avanos Medical position as of Q2 2015 after selling out during the quarter.
  • Symphony Asset Management sold 9,771 Avanos Medical shares in Q2 2015, an estimated $480K.
  • Symphony Asset Management first reported a position in Avanos Medical in Q1 2015 and held it in 1 quarter.
  • Symphony Asset Management's Avanos Medical position peaked at $480K in Q1 2015.
  • 419 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2015.

Based on Symphony Asset Management's 13F filing for Q2 2015, filed 12 Aug 2015.